AWS' Nova Act extension allows developers to build browser automation agents in their IDE, reducing the need to switch ...
Discover how Salt Security tackles API security in the era of agentic AI, protecting enterprises from rising risks and data ...
The FDA granted priority review for trastuzumab deruxtecan in combination with pertuzumab for first-line treatment of adults with unresectable or metastatic HER2-positive breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback